✦ LIBER ✦

Etoposide-cisplatin (EP) versus four-drug combination etoposide-cisplatin-epirubicin-cyclophosphamide (PCDE) in extensive disease small cell lung cancer (ED-SCLC). A FNCLCC phase III multicentre study

✍ Scribed by Pujol, J; Daures, J; Riviere, A; Quoix, E; Depierre, A; Breton, J.L; Lemarie, E; Poudex, M; Milleron, B; Moro, D; Debieuvre, D; Quantin, X; Le Chevalier, T

Book ID: 118569638
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 112 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80093-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter randomized phase III study

A multicenter randomized phase III study comparing paclitaxel-cisplatin-etoposide (TEP) versus cisplatin-etoposide (EP) as front-line treatment in patients with small cell lung cancer (SCLC)

✍ Mavroudis, D; Papadakis, E; Veslemes, M; Agelidou, M; Tsiafaki, X; Agelidou, G; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 103 KB

A randomized phase III study of irinotec

A randomized phase III study of irinotecan and cisplatin (CP) versus etoposide and cisplatin (EP) in extensive-disease small-cell lung cancer (ED-SCLC): Japan Clinical Oncology Group Study (JCOG 9511)

✍ Negoro, S; Noda, K; Nishiwaki, Y; Kawahara, M; Tamura, T; Sugiura, T; Yokayama, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Randomised Phase II study of topotecan/c

Randomised Phase II study of topotecan/cisplatin versus topotecan/etoposide in patients with untreated, extensive disease, small cell lung cancer (SCLC)

✍ Gervais, R; Quoix, E; Mattson, K; Schramel, F.M; Rivière, A; Fields, S; Wheatley 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Randomized study of cyclophosphamide, do

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: A phase III trial of the Southeastern Cancer Study Group

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 166 KB

P-795 Phase III study comparing cyclopho

P-795 Phase III study comparing cyclophosphamide, doxorubicin, and etoposide (CDE) to carboplatin and paclitaxel (CP) in patients (pts) with extensive disease small cell lung cancer (ED SCLC)

✍ Smit, E.; Groen, H.; Biesma, B.; vd Wilt, C.; Koolen, M.; de Jong, W.; van Tinte 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Schedule dependency of 21-day oral versu

Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: A randomized phase III study of the cancer and leukemia group B

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 272 KB